Table 2 Gender distribution and comorbidities in RA group
From: Circulating CTRP5 in rheumatoid arthritis: an exploratory biomarker study
Gender | ILD | Joint Erosion | |
|---|---|---|---|
Male | 22.70% | 35.90% | 64.86% |
Female | 77.30% | ||
From: Circulating CTRP5 in rheumatoid arthritis: an exploratory biomarker study
Gender | ILD | Joint Erosion | |
|---|---|---|---|
Male | 22.70% | 35.90% | 64.86% |
Female | 77.30% | ||